Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may help predict who will be readmitted to the hospital within a month, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.1
The U.S. Food and Drug Administration published a draft guidance titled, “Technical Considerations for Non-Clinical Assessment of Medical Devices Containing Nitinol,” which includes proposed recommendations on what manufacturers should include in their premarket submission of a device containing nitinol, an alloy of nickel and titanium.
A program designed to help heart attack patients with the transition from hospital to outpatient care can reduce readmissions and deaths and increase the number of patients keeping follow-up appointments, a new study suggests.
Medtronic’s Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S. Food and Drug Administration (FDA) indication for treatment of de novo chronic total occlusion (CTO) lesions.
When it comes to treatment options for a damaged heart valve, nothing is getting more attention than transcatheter treatments. The transcatheter treatment global market is expected to double in a few years according to a new BCC Research report, due to several factors.
Late-breaking results confirm the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis enables efficient identification of which patients, despite symptoms suggestive of coronary artery disease (CAD), have a low risk of adverse cardiovascular events and can safely avoid invasive testing out to one year.
As many as one in four patients who undergo cath lab interventions can benefit from a technology that identifies the location of stenoses not resolved by initially performed percutaneous coronary interventions (PCIs) to relieve restricted blood flow.
V-Wave Ltd. announced that renowned heart failure cardiologist William T. Abraham, M.D., is joining V-Wave as chief medical officer. Abraham makes this move to V-Wave after more than 16 years as director of the Division of Cardiovascular Medicine at the Ohio State University.
The U.S. Food and Drug Administration (FDA) cleared Abbott’s Resting Full-cycle Ratio (RFR) intravascular diagnostic test to identify significant narrowing of coronary arteries to determine the need for a stent or if a patient can be treated medically.
Healthcare today is largely woven together with electronic medical record (EMR) systems, which has led to the rapid attendance growth in the past decade at the annual Healthcare Information and Management Systems Society (HIMSS) meeting, now the world’s largest health informatics conference with more than 1,300 vendors on the vast expo floor. Here are six key takeaway […]
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!